OPKO Health Inc. (OPK) News

OPKO Health Inc. (OPK): $1.36

0.08 (+6.25%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Filter OPK News Items

OPK News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

OPK News Highlights

  • For OPK, its 30 day story count is now at 3.
  • Over the past 28 days, the trend for OPK's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about OPK are AMP, LI and SAVE.

Latest OPK News From Around the Web

Below are the latest news stories about OPKO HEALTH INC that investors may wish to consider to help them evaluate OPK as an investment opportunity.

OPKO Health commences private offering of convertible senior notes

More on OPKO Health

...

Seeking Alpha | January 3, 2024

Here's Why You Should Retain OPKO Health (OPK) Stock for Now

OPKO Health's (OPK) potential in Rayaldee raises optimism about the stock.

Yahoo | December 7, 2023

Why Is OPKO Health (OPK) Up 18.7% Since Last Earnings Report?

OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 6, 2023

BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing

BioReference® Health, LLC (BRH), a leading specialty laboratory in the United States, announced a strategic collaboration with Prognos Health, a pioneer in providing accessible, quality real world data ("RWD") for the pharmaceutical and life science industries. This collaborative arrangement will offer healthcare providers and researchers unique solutions to inform clinical studies and improve patient outcomes. Combining genetic data and critical biomarkers, means targeted precision therapies ba

Yahoo | November 28, 2023

Phillip Frost Spends US$1.3m On OPKO Health Stock

Those following along with OPKO Health, Inc. ( NASDAQ:OPK ) will no doubt be intrigued by the recent purchase of shares...

Yahoo | November 15, 2023

Q3 2023 OPKO Health Inc Earnings Call

Q3 2023 OPKO Health Inc Earnings Call

Yahoo | November 7, 2023

OPKO Health (OPK) Q3 Earnings Lag Estimates, Revenues Top

Despite OPKO Health's (OPK) robust RAYALDEE sales and strength in the Pharmaceuticals segment, its overall third-quarter results reflect soft performances.

Yahoo | November 7, 2023

OPKO Health, Inc. (NASDAQ:OPK) Q3 2023 Earnings Call Transcript

OPKO Health, Inc. (NASDAQ:OPK) Q3 2023 Earnings Call Transcript November 6, 2023 OPKO Health, Inc. misses on earnings expectations. Reported EPS is $-0.11 EPS, expectations were $-0.09. Operator: Hello and welcome to the OPKO Health Third Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there […]

Yahoo | November 7, 2023

BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that BioReference® Health, LLC, an OPKO Health, Inc. company and full-service laboratory that processes more than 12 million tests annually, will implement SOPHiA GENETICS' technology and add MSK-ACCESS® liquid biopsy to its test suite. With the implementation of SOPHiA GENETICS, BioReference will be the first laboratory globally to adopt MSK-ACCESS® powered with SOPHiA DDM™. The

Yahoo | November 7, 2023

Opko Health (OPK) Q3 2023 Earnings Call Transcript

Image source: The Motley Fool. Opko Health (NASDAQ: OPK)Q3 2023 Earnings CallNov 06, 2023, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorHello, and welcome to the OPKO Health third quarter 2023 financial results conference call.

Yahoo | November 7, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!